MedTrace Logo

Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

NCT00017628 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES:

I. Determine the efficacy, in terms of disease progression, of high-dose cyclophosphamide and total body irradiation with T lymphocyte-depleted autologous peripheral blood stem cell or bone marrow rescue in patients with multiple sclerosis.

Conditions

Interventions

DRUG

cyclophosphamide

DRUG

filgrastim

DRUG

methylprednisolone

PROCEDURE

Autologous Stem Cell Transplantation

Sponsors & Collaborators

  • Northwestern Memorial Hospital

    lead OTHER

Principal Investigators

  • Richard K. Burt · Northwestern Memorial Hospital

Study Design

Purpose
TREATMENT

Eligibility

Min Age
0 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00017628 on ClinicalTrials.gov